Status:

COMPLETED

Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

Lead Sponsor:

Deborah Gentile

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Upper Respiratory Infection

Eligibility:

All Genders

18-50 years

Phase:

PHASE4

Brief Summary

Assesses the efficacy of treatment with montelukast 10 mg PO QD x 5 days versus placebo for the treatment of viral-induced upper respiratory infection in healthy adults aged 18-50 years.

Detailed Description

This is a randomized double-blinded placebo controlled trial to assess the efficacy of treatment with montelukast 10 mg PO QD x 5 days versus placebo for the treatment of viral-induced upper respirato...

Eligibility Criteria

Inclusion

  • Adults 18 to 50 years of age.
  • Male or female, who are not pregnant or lactating.
  • Common cold symptoms for less than 24 hours.
  • At least 2 of the following 9 symptoms: cough, headache, hoarseness, muscle ache, nasal drainage, nasal congestion, scratch throat, sneezing and malaise.

Exclusion

  • Investigational medication in past 30 days.
  • Known hypersensitivity to any ingredients in study medication.
  • History of asthma or other chronic diseases.
  • Females of childbearing potential who are not using a medically acceptable form of birth control.
  • Patients with nasal ulcers within the past 1 month, nasal surgery within the past 6 months, nasal trauma within the past 2 months or presence of nasal polyps or nasal deformities causing significant nasal obstruction.
  • Females with a positive urinary HCG test.
  • Patients with a positive rapid antigen test for streptococcal infection.
  • Common cold symptoms for more than 24 hours.
  • Patients who are users of illicit drugs.
  • Patients who are on rifampin or phenobarbital.

Key Trial Info

Start Date :

October 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2007

Estimated Enrollment :

84 Patients enrolled

Trial Details

Trial ID

NCT00189475

Start Date

October 1 2003

End Date

July 1 2007

Last Update

November 18 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States, 15212